ArticleHepatology international2024
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease.
Abstract read
In one paragraph
Article in Hepatology international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Natural Plant-Derived Compounds Targeting Oxidative Stress and Inflammation in NAFLD-Mechanisms and Repositioning Potential.Current issues in molecular biology · 2026Review
- The Predictive Value of TyG-BMI and TG/HDL-C for Metabolic Dysfunction-Associated Steatotic Liver Disease in Obstructive Sleep Apnea: A Single-Center Retrospective Cohort Analysis.Journal of clinical medicine · 2026Article
- Metabolic dysfunction-associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad.European journal of clinical investigation · 2026Review
- Dynamic Alterations of BMP9 in NAFLD: A Novel Hepatokine Marker of Metabolic Dysfunction and Disease Severity.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Article
- Research Progress on Leptin in Metabolic Dysfunction-associated Fatty Liver Disease.Journal of clinical and translational hepatology · 2025Review
- Organokine-Mediated Crosstalk: A Systems Biology Perspective on the Pathogenesis of MASLD-A Narrative Review.International journal of molecular sciences · 2025Review
- Cardiovascular Health in the Shadow of Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Emerging Paradigm.Reviews in cardiovascular medicine · 2025Review
- Insulin resistance and cancer: molecular links and clinical perspectives.Molecular and cellular biochemistry · 2025Review
- Global burden and risk factors of MASLD: trends from 1990 to 2021 and predictions to 2030.Internal and emergency medicine · 2025Article
- Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and Sarcopenia.International journal of molecular sciences · 2025Review
- Outcomes of Concomitant Laparoscopic Sleeve Gastrectomy and Hiatal Hernia Repair on Gastroesophageal Reflux Disease in Patients with Severe Obesity: A Propensity Score-Matched Analysis.Obesity surgery · 2025Article
- Article
- Dynamic Status of Systemic Immune Inflammation Index Is Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: An Evidence From a Ten-Year Prospective Longitudinal Cohort Study.Journal of inflammation research · 2025Article
- Article
- Identification and Validation of Lipid Metabolism-Related Biomarkers GPD1 and CEBPD in Metabolic Dysfunction-Associated Steatohepatitis.Journal of inflammation research · 2025Article
- Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Short-Term Progression of Carotid Atherosclerosis Among Early Middle Age Adults.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025Article
- Urolithin A Protects Hepatocytes from Palmitic Acid-Induced ER Stress by Regulating Calcium Homeostasis in the MAM.Biomolecules · 2024Article
- Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease.Antioxidants (Basel, Switzerland) · 2024Review
- Metabolic-Associated Fatty Liver Disease: The Influence of Oxidative Stress, Inflammation, Mitochondrial Dysfunctions, and the Role of Polyphenols.Pharmaceuticals (Basel, Switzerland) · 2024Review
- The association between working hours and working type with non-alcoholic fatty liver disease: results from the NHANES 1999-2014.Frontiers in endocrinology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
95 authors.
Huai ZhangDepartment of Medical Record, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.ORCID http://orcid.org/0000-0001-7736-5719
Giovanni TargherMetabolic Diseases Research Unit, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, Italy.
Christopher D ByrneSouthampton National Institute for Health and Care Research Biomedical Research Centre, University Hospital Southampton and University of Southampton, Southampton General Hospital, Southampton, UK.
Seung Up KimDepartment of Internal Medicine, Yonsei University, Seoul, Korea.
Vincent Wai-Sun WongDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Luca ValentiDepartment of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Myer GlickmanHealth Analysis and Pandemic Insight Division, Office for National Statistics, London, UK.
Jaime PonceDepartment Bariatric Surgery, CHI Memorial Hospital, Chattanooga, TN, USA.
Christos S MantzorosBeth Israel Deaconess Medical Center and Boston VA Healthcare System, Harvard Medical School, Boston, MA, USA.
Javier CrespoGastroenterology and Hepatology Department, Clinical and Traslational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital, Santander, Spain.
Henning GronbaekDepartment of Hepatology and Gastroenterology, Aarhus University Hospital, 8200, Aarhus N, Denmark.
Wah YangDepartment of Metabolic and Bariatric Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Mohammed EslamStorr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney, NSW, Australia.
Robert J WongDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, Veterans Affairs Palo Alto Healthcare System, Palo Alto, USA.
Mariana Verdelho MachadoDepartment of Gastroenterology, Hospital de Vila Franca de Xira, Vila Franca de Xira, Portugal.
Ming-Lung YuSchool of Medicine and Doctoral Program of Clinical and Experimental Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-sen University, Kaohsiung, Taiwan.
Omar M GhanemDepartment of Surgery, Mayo Clinic, Rochester, MN, USA.
Takeshi OkanoueDepartment of Gastroenterology, Saiseikai Suita Hospital, Suita, Japan.
Jun-Feng LiuDepartment of Medical Records, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Yong-Ho LeeDepartment of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Xiao-Yuan XuDepartment of Infectious Diseases, Peking University First Hospital, Beijing, China.
Qiuwei PanDepartment of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.
Meili SuiDepartment of Medical Records Management, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Amedeo LonardoDepartment of Internal Medicine, Azienda Ospedaliero-Universitaria di Modena (-2023), Modena, Italy.
Yusuf YilmazDepartment of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey.
Li-Yong ZhuDepartment of Metabolic and Bariatric Surgery, The Third Xiangya Hospital, Central South University, Changsha, China.
Christophe MorenoDepartment of Gastroenterology, Hepatopancreatology and Digestive Oncology, C.U.B. Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Luca MieleDepartment of Medicina e Chirurgia Traslazionale, Università Cattolica Del Sacro Cuore, Rome, Italy.
Monica Lupsor-PlatonMedical Imaging Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, Regional Institute of Gastroenterology and Hepatology "Prof. Dr. Octavian Fodor", Cluj-Napoca, Romania.
Lei ZhaoDepartment of General Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
Teresa LeAnn LaMastersDepartment of Bariatric Surgery, UnityPoint Clinic Weight Loss, West Des Moines, USA.
Robert G GishMedical Director, Hepatitis B Foundation, Doylestown, PA, USA.
Huijie ZhangDepartment of Endocrinology and Metabolism, Nanfang Hospital Affiliated to Southern Medical University, Guangzhou, China.
Marius NedelcuDepartment of Bariatric Surgery, ELSAN, Clinique Bouchard, Marseille, France.
Wah Kheong ChanGastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Ming-Feng XiaDepartment of Endocrinology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Fernando BrilDivision of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, AL, USA.
Jun-Ping ShiDepartment of Hepatology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
Christian DatzDepartment of Internal Medicine, General Hospital Oberndorf, Teaching Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.
Stefano RomeoDepartment of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.
Jian SunDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Dan LiuDepartment of Medical Record Statistics, Guizhou Provincial People's Hospital, Guiyang, China.
Silvia SookoianConsejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
Yi-Min MaoDivision of Gastroenterology and Hepatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, NHC Key Laboratory of Digestive Diseases, Shanghai Research Center of Fatty Liver Disease, Shanghai, China.
Nahum Méndez-SánchezFaculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
Xiao-Yan WangChild Healthcare Center and Child Nutrition Center, Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing, China.
Nikolaos T PyrsopoulosDepartment of Medicine, Rutgers New Jersey Medical School, Newark, USA.
Jian-Gao FanDepartment of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yasser FouadDepartment of Gastroenterology, Hepatology and Endemic Medicine, Faculty of Medicine, Minia University Hospitals, Minya, Egypt.
Dan-Qin SunDepartment of Nephrology, Jiangnan University Medical Center, Wuxi, China.
Cosimo GianniniDepartment of Pediatrics, University of Chieti, Chieti, Italy.
Jin ChaiDepartment of Gastroenterology, Institute of Digestive Diseases of PLA, Cholestatic Liver Diseases Center and Center for Metabolic Dysfunction-Associated Fatty Liver Disease, the First Affiliated Hospital (Southwest Hospital), Third Military Medical University (Army Medical University), Chongqing, China.
Ze-Feng XiaDepartment of Gastrointestinal Surgery, Affiliated Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Dae Won JunDepartment of Internal Medicine, Hanyang University, College of Medicine, Seoul, Korea.
Guo-Jing LiDepartment of Medical Record, West China Hospital Affiliated to Sichuan University, Chengdu, China.
Sombat TreeprasertsukDepartment of Medicine, Chulalongkorn University, Bangkok, Thailand.
Ying-Xu LiDepartment of Bariatric Metabolic Surgery, The Second People's Hospital of Qujing, Qujing, China.
Tan To CheungDepartment of Surgery, Queen Mary Hospital and the University of Hong Kong Shenzhen Hospital, Li Ka Shing Faculty of Medicine, School of Clinical Medicine, the University of Hong Kong, Hong Kong, China.
Faming ZhangDepartment of Microbiota Medicine and Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
George Boon-Bee GohDepartment of Gastroenterology and Hepatology, Singapore General Hospital, Singapore, Singapore.
Masato FuruhashiDepartment of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Wai-Kay SetoDepartment of Medicine and State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, China.
Hui HuangDepartment of Cardiology, the Eighth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Anna Di SessaDepartment of Woman, Child and of General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Caserta, Italy.
Qing-Hong LiDepartment of Medical Record, China-Japan Friendship Hospital, Beijing, China.
Evangelos CholongitasFirst Department of Internal Medicine, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens "Laiko", Athens, Greece.
Le ZhangDepartment of Paediatrics, the Affiliated Children's Hospital of Jiangnan University, Wuxi, China.
Themis Reverbel SilveiraPrograma de Pós-Graduação em Pediatria, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
Giada SebastianiDivision of Gastroenterology and Hepatology, Department of Medicine, McGill University Health Center, Montreal, QC, Canada.
Leon A AdamsMedical School, University of Western Australia, Perth, Australia.
Wei ChenDepartment of Clinical Nutrition, Department of Health Medicine, Peking Union Medical College Hospital, Beijing, China.
Xiaolong QiCenter of Portal Hypertension, Department of Radiology, Affiliated Zhongda Hospital of Southeast University, Nanjing, China.
Ivan RankovicDepartment of Gastroenterology and Liver Unit, Royal Cornwall Hospitals NHS Trust, University of Exeter, Exeter, England, UK.
Victor De LedinghenHepatology Unit, University Hospital, CHU Bordeaux, Pessac, and INSERM 1312, Bordeaux University, Bordeaux, France.
Wen-Jie LvDepartment of Medical Record, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Masahide HamaguchiDepartment of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Radwan KassirDepartment of Bariatric Surgery, The View Hospital, Doha, Qatar.
Dirk Müller-WielandDepartment of Medicine I, University Hospital Aachen, Aachen, Germany.
Manuel Romero-GomezUCM Digestive Diseases, Virgen del Rocío University Hospital, Institute of Biomedicine of Seville (HUVR/CSIC/US), University of Seville, Seville, Spain.
Ying XuDepartment of Medical Record, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yi-Cong XuDepartment of Medical Record, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Shi-Yao ChenDepartment of Gastroenterology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Mohammad KermansaraviDepartment of Surgery, Division of Minimally Invasive and Bariatric Surgery, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mohammad Shafi KuchayDivision of Endocrinology and Diabetes, Medanta the Medicity Hospital, Gurugram, Haryana, India.
Sander LefereHepatology Research Unit, Department Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Chetan ParmarDepartment of General Surgery, Whittington Hospital, London, UK.
Gregory Y H LipLiverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK.
Chun-Jen LiuDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, China.
Fredrik ÅbergTransplantation and Liver Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
George LauHumanity and Health Clinical Trial Center, Hong Kong, China.
Jacob GeorgeStorr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney, NSW, Australia.
Shiv Kumar SarinDepartment of Hepatology and Liver Transplant, Institute of Liver and Biliary Sciences, New Delhi, India.
Jing-Ya ZhouDepartment of Medical Records, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. zhoujingya@pumch.cn.
Ming-Hua ZhengMAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. zhengmh@wmu.edu.cn.ORCID http://orcid.org/0000-0003-4984-2631
MAFLD ICD-11 coding collaborators
Funding
High-Level Creative Talents from the Department of Public Health in Zhejiang Province S2032102600032High-level Hospital Construction Project of Guangdong Provincial People's Hospital 2022-PUMCH-C-014Key Technologies Research and Development Program 2023YFA1800801National Natural Science Foundation of China 82070588National Natural Science Foundation of China 82370577
Abstract
backgroundWith the implementation of the 11th edition of the International Classification of Diseases (ICD-11) and the publication of the metabolic dysfunction-associated fatty liver disease (MAFLD) nomenclature in 2020, it is important to establish consensus for the coding of MAFLD in ICD-11. This will inform subsequent revisions of ICD-11.
methodsUsing the Qualtrics XM and WJX platforms, questionnaires were sent online to MAFLD-ICD-11 coding collaborators, authors of papers, and relevant association members.
resultsA total of 890 international experts in various fields from 61 countries responded to the survey. We also achieved full coverage of provincial-level administrative regions in China. 77.1% of respondents agreed that MAFLD should be represented in ICD-11 by updating NAFLD, with no significant regional differences (77.3% in Asia and 76.6% in non-Asia, p = 0.819). Over 80% of respondents agreed or somewhat agreed with the need to assign specific codes for progressive stages of MAFLD (i.e. steatohepatitis) (92.2%), MAFLD combined with comorbidities (84.1%), or MAFLD subtypes (i.e., lean, overweight/obese, and diabetic) (86.1%).
conclusionsThis global survey by a collaborative panel of clinical, coding, health management and policy experts, indicates agreement that MAFLD should be coded in ICD-11. The data serves as a foundation for corresponding adjustments in the ICD-11 revision.
Indexed as
International Classification of DiseasesNon-alcoholic Fatty Liver DiseaseGlobal HealthHumansSurveys and QuestionnairesGlobal surveyICD-11MAFLD
Identifiers
PMID
38878111What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.